ATE343398T1 - Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge - Google Patents
Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im augeInfo
- Publication number
- ATE343398T1 ATE343398T1 AT02747880T AT02747880T ATE343398T1 AT E343398 T1 ATE343398 T1 AT E343398T1 AT 02747880 T AT02747880 T AT 02747880T AT 02747880 T AT02747880 T AT 02747880T AT E343398 T1 ATE343398 T1 AT E343398T1
- Authority
- AT
- Austria
- Prior art keywords
- eye
- compositions
- methods
- hyperimmune reactions
- treating
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000006243 chemical reaction Methods 0.000 title abstract 3
- 230000000521 hyperimmunizing effect Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 abstract 2
- 102000008070 Interferon-gamma Human genes 0.000 abstract 2
- 108010074328 Interferon-gamma Proteins 0.000 abstract 2
- 208000022873 Ocular disease Diseases 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000030533 eye disease Diseases 0.000 abstract 1
- 229940044627 gamma-interferon Drugs 0.000 abstract 1
- 229960003130 interferon gamma Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29589501P | 2001-06-05 | 2001-06-05 | |
| US09/894,287 US6534059B2 (en) | 2001-06-05 | 2001-06-28 | Compositions and methods for treating hyperimmune response in the eye |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE343398T1 true ATE343398T1 (de) | 2006-11-15 |
Family
ID=26969391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02747880T ATE343398T1 (de) | 2001-06-05 | 2002-06-04 | Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6534059B2 (de) |
| EP (1) | EP1401496B1 (de) |
| JP (1) | JP2004532885A (de) |
| AT (1) | ATE343398T1 (de) |
| AU (1) | AU2002318175B2 (de) |
| CA (1) | CA2449488C (de) |
| DE (1) | DE60215649D1 (de) |
| WO (1) | WO2002098460A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6709655B2 (en) * | 2001-02-28 | 2004-03-23 | Instituto Bioclon, S.A. De C.V. | Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof |
| US6861056B2 (en) * | 2001-06-05 | 2005-03-01 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
| US6534059B2 (en) * | 2001-06-05 | 2003-03-18 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
| US6712976B2 (en) * | 2001-09-13 | 2004-03-30 | Abtech Industries, Inc. | Dual-action decontamination system |
| US7335759B2 (en) | 2002-12-02 | 2008-02-26 | Universidad Nacional Autónoma de Méxica (UNAM) | Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
| ES2339236T3 (es) * | 2003-07-25 | 2010-05-18 | Laboratorios Silanes, S.A. De C.V. | Administracion de fragmentos de anticuerpo f(ab')2 anti-tnf-alfa. |
| WO2006109191A2 (en) | 2005-01-27 | 2006-10-19 | Novimmune S.A. | Human anti-interferon gamma antibodies and methods of use thereof |
| US20100003264A1 (en) * | 2005-03-24 | 2010-01-07 | Washington University | Reduction of Ophthalmalogic Neovascularization |
| US7381802B2 (en) * | 2005-04-15 | 2008-06-03 | Universidad Nacional Autónoma De México (UNAM) | Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom |
| MX2008015976A (es) * | 2006-06-12 | 2009-04-14 | Therakine Ltd | Tratamiento topico para enfermedades de superficie ocular. |
| US8697046B2 (en) | 2008-08-15 | 2014-04-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of administering interferon gamma to absorb fluid from the subretinal space |
| WO2016177913A1 (en) | 2015-05-07 | 2016-11-10 | Novimmune Sa | Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of cxcl9 and other biomarkers |
| US11091543B2 (en) | 2015-05-07 | 2021-08-17 | Swedish Orphan Biovitrum Ag | Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| UA41863C2 (uk) | 1985-10-25 | 2001-10-15 | Займодженетікс Інк. | Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмах |
| WO1987002671A1 (en) | 1985-11-01 | 1987-05-07 | International Genetic Engineering, Inc. | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8905400D0 (en) * | 1989-03-09 | 1989-04-19 | Jonker Margreet | Medicaments |
| EP0610290B1 (de) * | 1991-10-04 | 1999-05-26 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen |
| US5888511A (en) | 1993-02-26 | 1999-03-30 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS |
| DE19535073C1 (de) * | 1995-09-21 | 1997-02-20 | Roland Dr Grosmann | Verfahren zur künstlichen Inkubation von Hühnereiern |
| US6861056B2 (en) * | 2001-06-05 | 2005-03-01 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
| US6534059B2 (en) * | 2001-06-05 | 2003-03-18 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
-
2001
- 2001-06-28 US US09/894,287 patent/US6534059B2/en not_active Expired - Fee Related
-
2002
- 2002-06-04 AT AT02747880T patent/ATE343398T1/de not_active IP Right Cessation
- 2002-06-04 JP JP2003501497A patent/JP2004532885A/ja active Pending
- 2002-06-04 AU AU2002318175A patent/AU2002318175B2/en not_active Ceased
- 2002-06-04 CA CA2449488A patent/CA2449488C/en not_active Expired - Fee Related
- 2002-06-04 EP EP02747880A patent/EP1401496B1/de not_active Expired - Lifetime
- 2002-06-04 WO PCT/US2002/017677 patent/WO2002098460A1/en active IP Right Grant
- 2002-06-04 DE DE60215649T patent/DE60215649D1/de not_active Expired - Lifetime
-
2003
- 2003-02-21 US US10/372,644 patent/US7232568B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20020182212A1 (en) | 2002-12-05 |
| CA2449488A1 (en) | 2002-12-12 |
| EP1401496A1 (de) | 2004-03-31 |
| HK1063601A1 (en) | 2005-01-07 |
| EP1401496A4 (de) | 2005-08-31 |
| US7232568B2 (en) | 2007-06-19 |
| US6534059B2 (en) | 2003-03-18 |
| EP1401496B1 (de) | 2006-10-25 |
| US20030224005A1 (en) | 2003-12-04 |
| DE60215649D1 (de) | 2006-12-07 |
| JP2004532885A (ja) | 2004-10-28 |
| CA2449488C (en) | 2010-02-09 |
| AU2002318175B2 (en) | 2006-01-05 |
| WO2002098460A1 (en) | 2002-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60215649D1 (de) | Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge | |
| IL148079A0 (en) | Human ctla-4 antibodies and compositions containing the same | |
| ATE448775T1 (de) | Rifalazil zur behandlung von infektionen mit clostridium difficile | |
| AU2003288675A8 (en) | Antibodies against PD-1 and uses therefor | |
| DE69935133D1 (de) | Antagoniste zur behandlung von cd11/cd18 adhäsionsrezeptor-vermittelten krankheiten | |
| BG110703A (en) | PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION | |
| WO2005059106A3 (en) | Interferon alpha antibodies and their uses | |
| DE60335552D1 (de) | Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen | |
| ATE202706T1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
| BR0008688A (pt) | Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18 | |
| DE60229059D1 (de) | Proteomimetische verbindungen und verfahren | |
| WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| EP1064308A4 (de) | Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen | |
| DE69325393D1 (de) | Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen | |
| ATE346867T1 (de) | Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten | |
| DE602004021847D1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| DE60313434D1 (de) | Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen | |
| DE60035693D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| ATE196083T1 (de) | Verwendung von ferrioxamin-b zur behandlung septischen schocks | |
| DE60326248D1 (de) | Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen | |
| WO2004024072A3 (en) | Novel compositions and methods for the treatment of immune related diseases | |
| WO2004083382A3 (en) | Compositions and methods for treating hyperimmune response in the eye | |
| DE60024997D1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
| ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
| ATE494903T1 (de) | Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |